Abstract
Background:
It is unknown whether maintaining normal blood pressure (BP) from middle into older age is associated with improved health outcomes.
Methods:
We estimated the proportion of Atherosclerosis Risk in Communities study participants who maintained normal BP from 1987–1989 (visit 1) through 1996–1998 and 2011–2013 (over 4 and 5 visits, respectively). Normal BP was defined as systolic BP<120 mmHg and diastolic BP<80 mmHg, without antihypertensive medication. We estimated the risk of cardiovascular disease (CVD), dementia, and poor physical functioning after visit 5. In exploratory analyses, we examined participant characteristics associated with maintaining normal BP.
Results:
Among 2,699 participants with normal BP at baseline (mean age 51.3 years), 47.1% and 15.0% maintained normal BP through visits 4 and 5, respectively. The hazard ratios comparing participants who maintained normal BP through visit 4 but not visit 5 and through visit 5 versus those who did not maintain normal BP through visit 4 were 0.80 (95%CI 0.63, 1.03) and 0.60 (95%CI 0.42, 0.86), respectively, for CVD, and 0.85 (95%CI 0.71, 1.01) and 0.69 (95%CI 0.54, 0.90), respectively, for poor physical functioning. Maintaining normal BP through visit 5 was more common among participants with normal body mass index (BMI) versus obesity at visit 1, and those with normal BMI at visits 1 and 5 and with overweight at visit 1 and overweight or normal BMI at visit 5, compared to those with obesity at visits 1 and 5.
Conclusions:
Maintaining normal BP was associated with lower risk of CVD and poor physical functioning.
Keywords: blood pressure, aging, obesity, cardiovascular disease
Graphical Abstract

INTRODUCTION
In contrast with several non-industrialized populations where systolic blood pressure (SBP) does not increase with age,1–3 in most industrialized settings including the United States (US), SBP increases with age.4 However, some individuals may experience only a minimal increase in blood pressure (BP) as they age and maintain normal BP across their life course.5,6 Determining whether maintaining normal BP from middle into older age is associated with lower CVD risk as compared to having normal BP only through midlife could inform public health programs focused on preventing the rise in BP.
Previous studies examining the maintenance of normal BP have not been able to follow participants into older age or have had relatively short follow up for CVD outcomes. In an analysis of the Coronary Artery Risk Development in Young Adults (CARDIA) study, which included adults aged 18–30 years with normal BP at baseline, 36% of participants maintained normal BP over 30 years.5 In the Jackson Heart Study, a cohort comprised of Black adults with mean age of 46.4 years at baseline, 35% of those with normal BP at baseline maintained normal BP over 8 years between study visits.6 Participants who maintained normal BP had a lower incidence of CVD over 5.9 years of subsequent follow up than those who did not have normal BP at baseline.6
We used data from the Atherosclerosis Risk in Communities (ARIC) Study to identify the proportion of participants who maintained normal BP through middle and into older age, over a period of more than 23 years from 1987–1989 to 2011–2013. We examined the association of maintaining normal BP with health outcomes important to older adults, including CVD, cognition, and physical functioning, with follow up from 2011–2013 through 2020. In exploratory analyses, we examined participant characteristics associated with maintaining normal BP.
METHODS
Study population
Instructions to access the dataset used for this study are available on the ARIC website (https://sites.cscc.unc.edu/aric). The ARIC Study enrolled 15,792 adults aged 45 to 64 years in 1987–1989 from Forsyth County, North Carolina, Jackson, Mississippi, Minneapolis, Minnesota, and Washington County, Maryland.7 To date, seven in-person visits have been conducted. The current analysis included Black and White participants with normal BP, as defined below, at visit 1 in 1987–1989 who attended visit 5 in 2011–2013 (Figure S1). We excluded participants missing information on the demographic characteristics, health behaviors, and psychosocial factors used in the current analysis. Institutional review boards at all sites approved the study procedures and all participants provided written informed consent at each visit.
Maintenance of normal BP
We used BP measurements from ARIC visits 1 through 5 (Figure 1). We did not investigate BP measurements at subsequent visits to allow follow up time for CVD, cognition, and physical functioning. BP measurement procedures are described in the Supplemental Methods.8 Normal BP was defined as SBP <120 mm Hg and diastolic BP (DBP) <80 mm Hg, without the self-reported use of antihypertensive medication. To be categorized as having maintained normal BP through a particular study visit, the participant was required to have normal BP at that visit and all available preceding visits. Participants with missing information on BP or antihypertensive medication use at any of the study visits were retained in the analysis, provided this information was available at visits 1 and 5. We categorized participants with normal BP at visit 1 as not maintaining normal BP through visit 4, maintaining normal BP through visit 4 but not visit 5, or maintaining normal BP through visit 5. These categories were chosen given the timing of the ARIC visits. The first 4 visits occurred at 3-year intervals (median of 8.9 years between visits 1 and 4), while visit 5 took place a median of 14.6 years after visit 4. This enabled us to examine maintenance of normal BP through middle age at visit 4 and into older age at visit 5. To retain as many participants in the analysis as possible, we allowed for missing data on BP measurements or antihypertensive medication use between visits 1 and 5, the handling of which is described in the Supplemental Methods.
Figure 1. Study schema showing the assessment of blood pressure from ARIC study visits 1 through 5 and follow up for incident outcomes.

Abbreviations: BP, Blood Pressure; CVD, Cardiovascular Disease.
Health outcomes
Incident CVD and dementia were assessed after visit 5. CVD outcomes included coronary heart disease (CHD), heart failure (HF), or stroke.9–12 Participants were followed for CVD events and dementia from visit 5 through the date of onset, last contact with the study, or administratively censored on December 31, 2020, whichever occurred first. Information on CVD and dementia ascertainment is provided in the Supplemental Methods.12–14 Physical functioning was assessed at visits 5, 6 and 7 using the Short Physical Performance Battery (SPPB), and poor physical functioning was defined as a SPPB score ≤ 6.15
Participant characteristics
Participant characteristics included in the analyses were chosen based on established relationships with BP. Demographic characteristics included age, sex, and race. We included race in this analysis as a marker for experiences of racialization and exposure to systemic racism, which influence opportunities for health over the life course.16 Education, height, weight, alcohol consumption, cigarette smoking, physical activity, and Dietary Approaches to Stop Hypertension (DASH) Diet score were assessed at visit 1.17,18 Body mass index (BMI) was calculated from measured height and weight. Psychosocial factors were assessed at visit 2 and included perceived social support,19,20 risk of isolation,20,21 and trait anger.22 Information on ascertainment of these characteristics is provided in Table S1. We used BMI, alcohol consumption, cigarette smoking, and physical activity measured at visit 5 to determine changes in these variables from visit 1 to visit 5. Changes were categorized to reflect having the same, improved or worsened levels of these risk factors.
Statistical analysis
We estimated the proportion of participants who did not maintain normal BP through visit 4, who maintained normal BP through visit 4 but not visit 5, and who maintained normal BP through visit 5, and assessed the distribution of participant characteristics among these categories.
We used Cox proportional hazards regression to estimate hazard ratios (HR) for incident CVD, CHD, HF, stroke, and dementia after visit 5 for those who maintained normal BP through visit 4 but not visit 5 and who maintained normal BP through visit 5, each compared to those who did not maintain normal BP through visit 4. These analyses were restricted to participants who had not experienced events prior to or at visit 5 with follow up data available after visit 5. First, we examined unadjusted associations of maintaining normal BP through visit 4 but not visit 5 and maintaining normal BP through visit 5 with incident outcomes. Next, we examined associations adjusted for age at visit 5 and sex, race, and education assessed at visit 1. Then, we adjusted for sex, race, and education at visit 1, and age, BMI, alcohol consumption, smoking, and physical activity at visit 5. Finally, we included adjustment for changes in BMI, drinking status, smoking status, and physical activity from visit 1 to visit 5 instead of these values at visit 5. We estimated HRs for poor physical function using discrete time survival analysis with complementary log-log regression models. Participants were followed through the first study visit at which they had poor physical function or until the last visit they attended. The regression models used the same adjustments described for the other health outcomes.
In exploratory analyses, we used Poisson regression models with robust variance estimates to examine associations of participant factors at baseline with maintaining normal BP through visit 4 and through visit 5, each versus not maintaining normal BP through visit 4. Also, we estimated the relative risk for maintaining normal BP through visit 5 versus maintaining normal BP through visit 4 but not visit 5. In post hoc analyses, we examined associations of obesity defined based on waist circumference and waist-to-hip ratio, separately, with maintaining normal BP.23,24 In sensitivity analyses, we used multilevel joint modeling multiple imputation to impute missing values for participant characteristics measured at baseline or visit 5 (Table S2) and repeated all analyses described above.25–27 Additional information on the exploratory and sensitivity analyses is available in the Supplemental Methods.
Analyses were conducted using Stata version 18 (StataCorp LLC, College Station, TX), SAS version 9.4 (SAS Institute Inc, Cary, NC), and R (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Proportion maintaining normal BP
Among 2,699 participants with normal BP at baseline who attended visit 5 (mean age at baseline, 51.3 years), 52.4% did not maintain normal BP through visit 4 which occurred a median of 8.9 years after the baseline visit (mean age at visit 4, 60.2 years). Among the remaining participants, 32.6% maintained normal BP through visit 4 but not visit 5 and 15.0% maintained normal BP through visit 5 over a median total follow up of 23.5 years (mean age at visit 5, 74.9 years). Characteristics of participants who did not maintain normal BP through visit 4, maintained normal BP through visit 4 but not visit 5, or maintained normal BP through visit 5 are provided in Table 1. Among those who maintained normal BP through visit 5, the mean SBP/DBP at visits 1 and 5 were 100.5/63.9 mm Hg and 110.2/59.2 mm Hg, respectively.
Table 1.
Visit 1 and visit 5 characteristics of participants who maintained and did not maintain normal blood pressure from ARIC visit 1 through ARIC visits 4 and 5.
| Characteristic, % | Did not maintain normal BP through visit 4 | Maintained normal BP through visit 4 but not visit 5* | Maintained normal BP through visit 5 |
|---|---|---|---|
| N (%) | 1415 (52.4%) | 880 (32.6%) | 404 (15.0%) |
| Age at visit 1, mean (SD) | 51.8 (5.0) | 50.8 (4.6) | 50.5 (4.7) |
| Age at visit 5, mean (SD) | 75.4 (5.1) | 74.5 (4.7) | 74.1 (4.8) |
| Female | 60.7% | 61.6% | 61.1% |
| Black | 13.6% | 9.7% | 6.2% |
| Education | |||
| <HS graduate | 11.2% | 8.6% | 6.9% |
| HS/GED/vocational school | 43.0% | 40.8% | 39.6% |
| At least some college | 45.8% | 50.6% | 53.5% |
| BMI category, visit 1 | |||
| Obesity | 18.3% | 9.1% | 9.9% |
| Overweight | 40.4% | 35.6% | 35.6% |
| Normal | 41.3% | 55.3% | 54.5% |
| BMI category, visit 5 | |||
| Obesity | 34.1% | 24.4% | 18.8% |
| Overweight | 40.3% | 41.6% | 38.4% |
| Normal | 25.7% | 34.0% | 42.8% |
| Drinking status, visit 1 | |||
| Current drinker | 65.2% | 67.8% | 67.6% |
| Former drinker | 14.7% | 14.1% | 12.6% |
| Never drinker | 20.1% | 18.1% | 19.8% |
| Drinking status, visit 5 | |||
| Current drinker | 56.0% | 57.6% | 56.4% |
| Former drinker | 26.2% | 24.9% | 24.5% |
| Never drinker | 17.7% | 17.5% | 19.1% |
| Smoking status, visit 1 | |||
| Current | 18.6% | 21.5% | 17.6% |
| Former | 34.2% | 31.4% | 28.5% |
| Never | 47.2% | 47.2% | 54.0% |
| Smoking status, visit 5 | |||
| Current | 5.8% | 8.2% | 8.4% |
| Former | 54.1% | 52.5% | 46.0% |
| Never | 40.1% | 39.3% | 45.5% |
| Physical activity at visit 1, MVPA/week | |||
| 0 minutes | 29.0% | 26.1% | 24.8% |
| 1–149 minutes | 27.2% | 28.9% | 30.0% |
| ≥150 minutes | 43.7% | 45.0% | 45.3% |
| Physical activity at visit 5, MVPA/week | |||
| 0 minutes | 30.0% | 25.5% | 23.0% |
| 1–149 minutes | 18.9% | 17.5% | 15.8% |
| ≥150 minutes | 51.1% | 57.0% | 61.1% |
| DASH diet score at visit 1, mean (SD) | 24.8 (4.8) | 24.8 (4.8) | 25.2 (4.7) |
| Perceived social support at visit 2 | |||
| Quartile 1 (Lowest) | 30.9% | 33.0% | 34.7% |
| Quartile 2 | 27.0% | 26.0% | 25.2% |
| Quartile 3 | 24.8% | 22.5% | 22.8% |
| Quartile 4 (Highest) | 17.3% | 18.5% | 17.3% |
| Lubben social network scale at visit 2 | |||
| Isolated or high risk for isolation | 5.9% | 6.4% | 6.2% |
| Moderate risk | 11.8% | 11.9% | 11.4% |
| Low risk | 82.3% | 81.7% | 82.4% |
| Spielberger Trait Anger at visit 2 | |||
| High | 7.8% | 6.0% | 5.4% |
| Moderate | 56.5% | 56.6% | 55.2% |
| Low | 35.7% | 37.4% | 39.4% |
| SBP at visit 1, mean (SD) | 109.0 (6.9) | 102.9 (8.0) | 100.5 (7.8) |
| DBP at visit 1, mean (SD) | 68.5 (6.3) | 65.0 (6.8) | 63.9 (7.0) |
| SBP at visit 5, mean (SD) | 131.3 (18.0) | 129.4 (13.6) | 110.2 (7.4) |
| DBP at visit 5, mean (SD) | 66.6 (10.6) | 66.8 (9.8) | 59.2 (7.3) |
| Antihypertensive medication use at visit 5 | 66.6% | 43.3% | 0.0% |
Abbreviations: ARIC, Atherosclerosis Risk in Communities; BMI, body mass index; BP, blood pressure; DASH, Dietary Approaches to Stop Hypertension; DBP, Diastolic Blood Pressure; HS, High School; MVPA, Moderate-Vigorous Physical Activity; SBP, Systolic Blood Pressure; SD, Standard Deviation.
Thirteen participants with missing BP at visit 4 who met criteria for normal BP at previous study visits, but had BP above normal at visit 5, are included in this category. Additionally, there was one participant missing BP at visit 4 who met criteria for normal BP at previous study visits who had normal BP at visit 5.
Association of maintaining normal BP with CVD, dementia, and physical function
In unadjusted analyses, maintaining normal BP through visit 4 but not visit 5 and through visit 5, versus not maintaining normal BP through visit 4, were associated with a lower risk of CVD, CHD, HF, dementia, and poor physical function (Table S3). After adjustment for characteristics at visit 5, the HRs comparing participants who maintained normal BP through visit 4 but not visit 5 and through visit 5 versus those who did not maintain normal BP through visit 4 were 0.80 (95% CI 0.63–1.03) and 0.60 (95% CI 0.42–0.86), respectively, for incident CVD; 0.69 (95% CI 0.47–1.02) and 0.36 (95% CI 0.18–0.73), respectively, for incident CHD, and; 0.68 (95% CI 0.50–0.94) and 0.64 (95% CI 0.41–1.00), respectively, for incident HF (Figure 2). Maintaining normal BP through visit 4 but not visit 5 and maintaining normal BP through visit 5 were not associated with the incidence of stroke. After adjustment, there was no evidence of an association of maintaining normal BP through visit 4 but not visit 5 or maintaining normal BP through visit 5 with incident dementia. After adjustment and compared with not maintaining normal BP through visit 4, the HRs for poor physical function associated with maintaining normal BP through visit 4 but not visit 5 and with maintaining normal BP through visit 5 were 0.85 (95% CI 0.71–1.01) and 0.69 (95% CI 0.54–0.90), respectively. The HRs adjusted for changes in BMI, drinking status, smoking status, and physical activity from visit 1 to visit 5, rather than at visit 5, are provided in Figure S2.
Figure 2. Adjusted hazard ratios for incident cardiovascular disease, dementia, and poor physical functioning after visit 5 associated with maintenance of normal blood pressure at visits 4 and 5 among participants who had normal blood pressure at visit 1 in midlife.

Abbreviations: BP, Blood Pressure; CI, Confidence Interval; HR, Hazard Ratio.
Any cardiovascular disease (CVD) defined as coronary heart disease (CHD), heart failure (HF), or stroke. Analyses of incident CVD, CHD, HF, stroke, and dementia exclude participants with the relevant condition at or before visit 5. Poor physical function defined as Short Physical Performance Battery (SPPB) score ≤6.
Models adjusted for sex, race, and education at visit 1, and age, body mass index, drinking status, smoking status, and physical activity at visit 5.
Factors associated with maintaining normal BP
Factors at baseline
In unadjusted, demographics-adjusted, and fully adjusted models, older age and Black race were associated with a lower likelihood of maintaining normal BP through visit 4 (Table S4, Table 2). Having overweight or normal BMI versus obesity and low versus high trait anger were associated with a higher likelihood of maintaining normal BP through visit 4. Older age and Black race were associated with a lower likelihood, while having a normal BMI was associated with a higher likelihood, of maintaining versus not maintaining normal BP through visit 5 in unadjusted and adjusted models. Among those who maintained normal BP through visit 4, Black participants were less likely to maintain normal BP through visit 5. No other factors were associated with maintaining normal BP through visits 4 and 5.
Table 2.
Baseline characteristics associated with maintaining normal blood pressure through visit 4 and visit 5.
| Baseline characteristics | Maintained normal BP through visit 4 versus did not maintain normal BP through visit 4 Relative risk (95% CI)* |
Maintained normal BP through visit 5 versus did not maintain normal BP through visit 5 Relative risk (95% CI)* |
Maintained normal BP through visit 5 versus maintained normal BP through visit 4 but not visit 5 Relative risk (95% CI)* |
|---|---|---|---|
| Age, per 5 years | 0.87 (0.83, 0.91) | 0.81 (0.73, 0.90) | 0.93 (0.85, 1.02) |
| Female sex (vs male) | 0.95 (0.87, 1.04) | 0.88 (0.71, 1.07) | 0.92 (0.76, 1.11) |
| Black race (vs White) | 0.77 (0.66, 0.90) | 0.52 (0.35, 0.78) | 0.67 (0.47, 0.97) |
| Education | |||
| <HS graduate | REF | REF | REF |
| HS/GED/vocational school | 1.05 (0.89, 1.23) | 1.11 (0.76, 1.63) | 1.04 (0.73, 1.47) |
| At least some college | 1.12 (0.95, 1.32) | 1.23 (0.84, 1.81) | 1.08 (0.76, 1.53) |
| BMI category | |||
| Obesity | REF | REF | REF |
| Overweight | 1.38 (1.17, 1.62) | 1.27 (0.91, 1.78) | 0.94 (0.70, 1.26) |
| Normal | 1.67 (1.42, 1.95) | 1.48 (1.08, 2.04) | 0.90 (0.68, 1.20) |
| Alcohol consumption | |||
| Current | REF | REF | REF |
| Former | 1.01 (0.89, 1.14) | 0.97 (0.74, 1.29) | 0.98 (0.76, 1.27) |
| Never | 1.04 (0.93, 1.16) | 1.16 (0.91, 1.48) | 1.09 (0.88, 1.35) |
| Smoking status | |||
| Current | REF | REF | REF |
| Former | 0.92 (0.82, 1.03) | 0.96 (0.73, 1.27) | 1.04 (0.81, 1.35) |
| Never | 0.99 (0.89, 1.10) | 1.20 (0.93, 1.54) | 1.22 (0.96, 1.54) |
| Physical activity, MVPA/week | |||
| 0 mins | REF | REF | REF |
| 1–149 mins | 1.05 (0.95, 1.17) | 1.06 (0.83, 1.36) | 1.01 (0.81, 1.27) |
| ≥150 mins | 1.03 (0.93, 1.14) | 0.99 (0.79, 1.26) | 0.96 (0.77, 1.18) |
| DASH diet score, per point | 1.00 (0.99, 1.01) | 1.02 (0.995, 1.04) | 1.02 (0.997, 1.03) |
| Perceived social support† | |||
| Quartile 1 (Lowest) | REF | REF | REF |
| Quartile 2 | 0.94 (0.85, 1.04) | 0.90 (0.71, 1.13) | 0.95 (0.77, 1.17) |
| Quartile 3 | 0.93 (0.83, 1.03) | 0.92 (0.72, 1.18) | 0.99 (0.80, 1.24) |
| Quartile 4 (Highest) | 1.00 (0.88, 1.13) | 0.94 (0.71, 1.25) | 0.94 (0.73, 1.22) |
| Lubben social network scale† | |||
| Isolated or high risk for isolation | REF | REF | REF |
| Moderate risk | 0.97 (0.80, 1.17) | 0.93 (0.59, 1.47) | 0.95 (0.63, 1.45) |
| Low risk | 0.96 (0.81, 1.14) | 0.93 (0.62, 1.40) | 0.98 (0.68, 1.42) |
| Spielberger Trait Anger† | |||
| High | REF | REF | REF |
| Moderate | 1.19 (0.99, 1.42) | 1.21 (0.81, 1.83) | 1.02 (0.71, 1.49) |
| Low | 1.22 (1.02, 1.47) | 1.30 (0.85, 1.98) | 1.07 (0.73, 1.57) |
Abbreviations: BMI, Body Mass Index; BP, blood pressure; CI: Confidence Interval; DASH, Dietary Approaches to Stop Hypertension; HS, High School; MVPA, Moderate-Vigorous Physical Activity. Bold indicates statistically significant at P < 0.05.
Adjusted for: Age, sex, race, education, BMI, alcohol consumption, smoking status, physical activity, and DASH diet score measured at visit 1, and psychosocial factors measured at visit 2.
Measured at visit 2.
When defined based on waist circumference or waist-to-hip ratio, not having versus having obesity was associated with a higher likelihood of maintaining normal BP through visit 4 (Table S5).
Changes in factors from visit 1 to visit 5
In unadjusted, demographics-adjusted, and fully adjusted models, participants with normal BMI at visits 1 and 5, and those with overweight at visit 1 who had overweight or normal BMI at visit 5, were more likely to maintain normal BP through visit 5 compared to those who had obesity at visits 1 and 5 (Table S6). The changes in other factors were not associated with maintaining normal BP through visit 5 from baseline or from visit 4 in fully adjusted models.
Associations of changes in obesity status defined based on waist circumference and waist-to-hip ratio with maintaining normal BP through visit 5 from baseline or from visit 4 are presented in Table S7.
Sensitivity analyses – Multiple imputation
Multiple imputation of missing covariate information did not substantively change the results. After performing multiple imputation, 51.4% of participants did not maintain normal BP through visit 4, 34.0% of participants maintained normal BP through visit 4 but not visit 5, and 14.6% of participants maintained normal BP through visit 5. Maintaining normal BP through visit 4 but not visit 5 and through visit 5 was associated with lower risk of incident CVD, CHD, HF, and poor physical function (Table S8). After adjustment, there was no association of maintaining normal BP with incident stroke or dementia. The associations of baseline participant characteristics, and changes in participant characteristics between visits 1 and 5, with maintaining normal BP after multiple imputation are presented in Tables S9 and S10.
DISCUSSION
The current study has several important findings, which have clinical and public health implications. Overall, 15.0% of participants 45–64 years old at baseline maintained normal BP over 23.5 years of follow-up, at which time their mean age was nearly 75 years. The risks of incident CVD, CHD, HF and poor physical function were lower in participants who maintained versus did not maintain normal BP. In exploratory analyses, having normal BMI at baseline, as well as having normal BMI at both visit 1 and visit 5, were associated with a higher likelihood of maintaining normal BP. Additionally, participants who were older at baseline and Black participants were less likely to maintain normal BP.
A recent modeling study estimated 40% of all CVD events are attributable to SBP and DBP above the normal range.28 Therefore, maintaining normal BP across the life course is an important public health goal for preventing CVD. The current study extends previous work conducted among younger and middle-aged adults5,6 and provides evidence for maintaining normal BP into older age as an achievable goal. In the subgroup who maintained normal BP from midlife through older adulthood, SBP was on average 100.5 mm Hg at baseline and increased by a mean of 9.7 mm Hg over 23.5 years, or approximately 4 mm Hg per decade. The current results support prior studies showing that SBP in early life is a strong predictor of future SBP and the development of hypertension.29 Having lower SBP in early and midlife may be important for mitigating the increase in SBP that typically occurs with age.29,30
The current study provides evidence of the importance of maintaining normal BP into older age for the prevention of incident CVD, CHD, HF, and poor physical function. However, there was no association with the risk of stroke or dementia. A prior analysis of ARIC study data found no difference in stroke risk in those with SBP <120 mm Hg at visit 1 whose SBP increased to ≥120 mm Hg at visit 4 versus those with SBP <120 mm Hg from visits 1 to 4.31 Another analysis of BP patterns in ARIC found no difference in dementia risk for participants who did not have hypertension in midlife but had hypertension in late-life compared to those without hypertension in mid- and late-life.13 The current study results are consistent with these prior analyses. As we restricted the study population to participants with normal BP at baseline, we were unable to examine the relationship between midlife BP and the risk for stroke and dementia associated, which may be stronger than the relationship in late-life.32–34 The current study differs from previous analyses because it focused on the maintenance of normal BP into older age, not only the absence of hypertension.
Participants who maintained normal BMI from midlife to older adulthood and those with overweight in midlife who maintained or lost weight were more likely to maintain normal BP through older adulthood compared to those with obesity.5,6,35 In the US, more than 40% of adults have obesity,36 which suggests that maintenance of normal weight or weight loss may be important public health interventions for preventing elevated BP and hypertension. Randomized controlled trials have shown weight loss reduces BP.37 However, there are few data demonstrating weight loss interventions in randomized trials can be translated into community-based settings and reach populations before they develop hypertension. The American Heart Association-funded RESTORE (addREssing Social determinants TO pRevent hypErtension) Network, which is testing the implementation of community-based approaches to prevent hypertension, including dietary and physical activity interventions, in populations with elevated BP.38
The current study has several potential and known limitations. We did not have BP data available before the ARIC baseline visit when participants were 45 to 64 years of age. We may have included participants who had elevated BP or hypertension before but not at baseline or excluded participants who maintained normal BP into their sixties but had elevated BP or hypertension at baseline. Due to missing data, some misclassification of the maintenance of normal BP may have been possible. We did not consider BP measurements at visits 6 or 7 and some participants who maintained normal BP through visit 5 may not have continued to maintain normal BP. This study may be subject to bias due to selective attrition and death. For example, if participants who did not maintain normal BP were more likely to have dementia and die prior to a cognitive evaluation at visit 6 or 7. However, in that situation, the effect estimates would likely be attenuated. We estimated associations of a large number of participant characteristics with maintenance of normal BP. Therefore, the analyses should be considered exploratory, and the results interpreted with caution.39 Additionally, changes in participant characteristics between visits 1 and 5 may not capture potentially clinically relevant fluctuations in these characteristics that may have occurred between timepoints. We acknowledge the need for better, direct measures of racialized experiences and exposure to systemic racism, which may affect BP levels. Many of the factors we examined were assessed by self-report. The psychosocial variables were assessed at visit 2 and not at visit 1. We were unable to assess potentially important variables such as usual sodium intake, which is not captured well by food frequency questionnaires,40 or sleep characteristics which were not assessed in the full ARIC cohort.
Perspectives
The current study suggests that maintaining normal BP into older age is achievable and is associated with a lower risk for incident CVD and poor physical function.
Supplementary Material
Novelty and Relevance.
What Is New?
We assessed whether maintaining normal blood pressure (BP) from middle into older age is associated with health outcomes important to older adults, including CVD, dementia, and poor functioning.
What Is Relevant?
Among participants 45–64 years of age at baseline with normal BP, 15.0% maintained normal BP over a median of 23.5 years.
Maintaining normal BP was associated with lower risk of CVD and poor physical function.
Having a normal body mass index (BMI) at baseline and maintaining a normal BMI were associated with maintaining normal BP.
Clinical/Pathophysiological Implications?
Maintaining normal BP into older age is achievable and associated with lower risk of incident CVD and poor physical functioning.
Maintaining normal BMI may be important for maintaining normal BP.
Acknowledgements
The authors thank the staff and participants of the ARIC study for their important contributions. The authors thank Dr. Ligong Chen for providing expertise on the statistical analysis.
Funding
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, 75N92022D00005). The ARIC Neurocognitive Study is supported by U01HL096812, U01HL096814, U01HL096899, U01HL096902, and U01HL096917 from the NIH (NHLBI, NINDS, NIA and NIDCD).
ABBREVIATIONS
- ARIC
Atherosclerosis Risk in Communities
- BMI
Body mass index
- BP
Blood pressure
- CHD
Coronary heart disease
- CVD
Cardiovascular disease
- DASH
Dietary Approaches to Stop Hypertension
- DBP
Diastolic blood pressure
- HF
Heart failure
- HR
Hazard ratio
- SBP
Systolic blood pressure
- SPPB
Short Physical Performance Battery
- US
United States
Footnotes
Disclosures
The authors have no relevant disclosures.
REFERENCES
- 1.Mueller NT, Noya-Alarcon O, Contreras M, Appel LJ, Dominguez-Bello MG. Association of Age with Blood Pressure Across the Lifespan in Isolated Yanomami and Yekwana Villages. JAMA Cardiol. 2018;3(12):1247–1249. doi: 10.1001/jamacardio.2018.3676 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Carvalho JJM, Baruzzi RG, Howard PF, et al. Blood pressure in four remote populations in the INTERSALT study. Hypertension. 1989;14(3):238–246. doi: 10.1161/01.HYP.14.3.238 [DOI] [PubMed] [Google Scholar]
- 3.Waldron I, Nowotarski M, Freimer M, Henry JP, Post N, Witten C. Cross-cultural variation in blood pressure: A quantitative analysis of the relationships of blood pressure to cultural characteristics, salt consumption and body weight. Soc Sci Med. 1982;16(4):419–430. doi: 10.1016/0277-9536(82)90050-8 [DOI] [PubMed] [Google Scholar]
- 4.Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States. J Am Med Assoc. 2003;289(18):2363–2369. doi: 10.1001/jama.289.18.2363 [DOI] [PubMed] [Google Scholar]
- 5.Reges O, Krefman AE, Hardy ST, et al. Decision Tree-Based Classification for Maintaining Normal Blood Pressure Throughout Early Adulthood and Middle Age: Findings From the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Hypertens. 2021;34(10):1037–1041. doi: 10.1093/ajh/hpab099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hardy ST, Sakhuja S, Jaeger BC, et al. Maintaining Normal Blood Pressure Across the Life Course. Hypertension. 2021;(May):1–10. doi: 10.1161/hypertensionaha.120.16278 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wright JD, Folsom AR, Coresh J, et al. The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8. J Am Coll Cardiol. 2021;77(23):2939–2959. doi: 10.1016/j.jacc.2021.04.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Abdalla M, Booth JN, Seals SR, et al. Masked Hypertension and Incident Clinic Hypertension Among Blacks in the Jackson Heart Study. Hypertension. 2016;68(1):220–226. doi: 10.1161/HYPERTENSIONAHA.115.06904 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years’ experience. J Clin Epidemiol. 1996;49(2):223–233. doi: 10.1016/0895-4356(95)00041-0 [DOI] [PubMed] [Google Scholar]
- 10.Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart Failure Incidence and Survival (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2008;101(7):1016–1022. doi: 10.1016/j.amjcard.2007.11.061 [DOI] [PubMed] [Google Scholar]
- 11.Rosamond WD, Folsom AR, Chambless LE, et al. Stroke Incidence and Survival Among Middle-Aged Adults. Stroke. 1999;30(4):736–743. doi: 10.1161/01.STR.30.4.736 [DOI] [PubMed] [Google Scholar]
- 12.ARIC Study. ARIC Cohort Surveillance Incident Events Derived Variable Dictionary. https://aric.cscc.unc.edu/aric9/event_surveillance/Surveillance_Data_Collection_Dictionaries Accessed on September 20, 2023.
- 13.Walker KA, Sharrett AR, Wu A, et al. Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia. JAMA. 2019;322(6):535. doi: 10.1001/jama.2019.10575 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Knopman DS, Gottesman RF, Sharrett AR, et al. Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimers Dement Amst Neth. 2016;2:1–11. doi: 10.1016/j.dadm.2015.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Guralnik JM, Simonsick EM, Ferrucci L, et al. A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission. J Gerontol Med Sci. 1994;49(2):85–94. [DOI] [PubMed] [Google Scholar]
- 16.Lett E, Asabor E, Beltrán S, Cannon AM, Arah OA. Conceptualizing, Contextualizing, and Operationalizing Race in Quantitative Health Sciences Research. Ann Fam Med. 2022;20(2):157–163. doi: 10.1370/afm.2792 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Shimakawa T, Sorlie P, Carpenter MA, et al. Dietary Intake Patterns and Sociodemographic Factors in the Atherosclerosis Risk in Communities Study. Prev Med. 1994;23(6):769–780. doi: 10.1006/pmed.1994.1133 [DOI] [PubMed] [Google Scholar]
- 18.Rebholz CM, Crews DC, Grams ME, et al. DASH (Dietary Approaches to Stop Hypertension) Diet and Risk of Subsequent Kidney Disease. Am J Kidney Dis. 2016;68(6):853–861. doi: 10.1053/j.ajkd.2016.05.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Payne TJ, Andrew M, Butler KR, Wyatt SB, Dubbert PM, Mosley TH. Psychometric Evaluation of the Interpersonal Support Evaluation List–Short Form in the ARIC Study Cohort. SAGE Open. 2012;2(3):2158244012461923. doi: 10.1177/2158244012461923 [DOI] [Google Scholar]
- 20.Kats D, Patel MD, Palta P, et al. Social support and cognition in a community-based cohort: the Atherosclerosis Risk in Communities (ARIC) study. Age Ageing. 2016;45(4):475–480. doi: 10.1093/ageing/afw060 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lubben JE. Assessing social networks among elderly populations. Fam Community Health. 1988;11(3):42–52. [Google Scholar]
- 22.Spielberger CD, Jacobs G, Russell S, Butcher J. Assessment of: the state-trait anger scale. In: Butcher JN, Spielberger CD, editors. Advances in Personality Assessment. 2nd ed. Lawrence Erlbaum Associates; 1983:161–189. [Google Scholar]
- 23.Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143:CIR.0000000000000973. doi: 10.1161/CIR.0000000000000973 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.World Health Organization. Waist circumference and waist-hip ratio : report of a WHO expert consultation, Geneva, 8–11 December 2008. Published online 2011. Accessed September 23, 2023. https://iris.who.int/handle/10665/44583
- 25.Goldstein H, Carpenter J, Kenward MG, Levin KA. Multilevel models with multivariate mixed response types. Stat Model. 2009;9(3):173–197. doi: 10.1177/1471082X0800900301 [DOI] [Google Scholar]
- 26.Huque MH, Carlin JB, Simpson JA, Lee KJ. A comparison of multiple imputation methods for missing data in longitudinal studies. BMC Med Res Methodol. 2018;18(1):168. doi: 10.1186/s12874-018-0615-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Quartagno M, Carpenter J. jomo: Multilevel Joint Modelling Multiple Imputation. Published online April 15, 2023. Accessed October 25, 2023. https://cran.r-project.org/web/packages/jomo/index.html
- 28.Bundy JD, Zhu Z, Ning H, Zhong VW, Whelton PK. Estimated Impact of Achieving Optimal Cardiovascular Health Among US Adults on Cardiovascular Disease Events. J Am Heart Assoc. 2021;10:e019681. doi: 10.1161/JAHA.120.019681 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: The Bogalusa heart study*. Am J Hypertens. 1995;8(7):657–665. doi: 10.1016/0895-7061(95)00116-7 [DOI] [PubMed] [Google Scholar]
- 30.Wills AK, Lawlor DA, Matthews FE, et al. Life Course Trajectories of Systolic Blood Pressure Using Longitudinal Data from Eight UK Cohorts. Caulfield MJ, ed. PLoS Med. 2011;8(6):e1000440. doi: 10.1371/journal.pmed.1000440 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Petruski-Ivleva N, Viera AJ, Shimbo D, et al. Longitudinal Patterns of Change in Systolic Blood Pressure and Incidence of Cardiovascular Disease. Hypertension. 2016;67(6):1150–1156. doi: 10.1161/HYPERTENSIONAHA.115.06769 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Walker KA, Power MC, Gottesman RF. Defining the relationship between hypertension, cognitive decline, and dementia: a review. Curr Hypertens Rep. 2017;19(3):24. doi: 10.1007/s11906-017-0724-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Ou YN, Tan CC, Shen XN, et al. Blood Pressure and Risks of Cognitive Impairment and Dementia. Hypertension. 2020;76(1):217–225. doi: 10.1161/HYPERTENSIONAHA.120.14993 [DOI] [PubMed] [Google Scholar]
- 34.Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet. 2002;360(9349):1903–1913. doi: 10.1016/S0140-6736(02)11911-8 [DOI] [PubMed] [Google Scholar]
- 35.Muntner P, Jaeger BC, Hardy ST, et al. Age-Specific Prevalence and Factors Associated With Normal Blood Pressure Among US Adults. Am J Hypertens. 2022;35(4):319–327. doi: 10.1093/AJH/HPAB154 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hales C, Carroll M, Fryar C, Ogden C. Prevalence of Obesity and Severe Obesity among Adults: United States, 2017–2018. NCHS Data Brief, No 360. National Center for Health Statistics; 2020. Accessed February 19, 2021. https://www.cdc.gov/nchs/products/databriefs/db360.htm [PubMed] [Google Scholar]
- 37.Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of Weight Reduction on Blood Pressure. Hypertension. 2003;42(5):878–884. doi: 10.1161/01.HYP.0000094221.86888.AE [DOI] [PubMed] [Google Scholar]
- 38.Spruill TM, Muntner P, Popp CJ, et al. AddREssing Social Determinants TO pRevent hypErtension (The RESTORE Network): Overview of the Health Equity Research Network to Prevent Hypertension. Am J Hypertens. 2023;36(5):232–239. doi: 10.1093/ajh/hpad010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Westreich D, Greenland S. The Table 2 Fallacy: Presenting and Interpreting Confounder and Modifier Coefficients. Am J Epidemiol. 2013;177(4):292–298. doi: 10.1093/aje/kws412 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.McLean RM, Farmer VL, Nettleton A, Cameron CM, Cook NR, Campbell NRC. Assessment of dietary sodium intake using a food frequency questionnaire and 24‐hour urinary sodium excretion: a systematic literature review. J Clin Hypertens. 2017;19(12):1214–1230. doi: 10.1111/jch.13148 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
